Cho Jai Young, Han Ho-Seong, Choi YoungRok, Yoon Yoo-Seok, Kim Sungho, Choi Jang Kyu, Jang Jae Seong, Kwon Seong Uk, Kim Haeryoung
Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
JAMA Surg. 2017 Apr 1;152(4):386-392. doi: 10.1001/jamasurg.2016.5040.
The remnant liver after hepatectomy may have inadequate blood supply, especially following nonanatomical resection or vascular damage.
To evaluate whether remnant liver ischemia (RLI) may have an adverse effect on long-term survival and morbidity after liver resection in patients with hepatocellular carcinoma.
DESIGN, SETTING, AND PARTICIPANTS: This study was a retrospective analysis at Seoul National University Bundang Hospital. Remnant liver ischemia was graded on postoperative computed tomographic scans in 328 patients who underwent hepatectomy for hepatocellular carcinoma between January 1, 2004, and December 31, 2013.
Remnant liver ischemia was defined as reduced or absent contrast enhancement during the venous phase. Remnant liver ischemia was classified as minimal (none or marginal) or severe (partial, segmental, or necrotic).
Among 328 patients (252 male and 76 female; age range, 26-83 years [mean age, 58.2 years]), radiologic signs of severe RLI were found in 98 patients (29.9%), of whom 63, 16, and 19 had partial, segmental, or necrotic RLI, respectively. These patients experienced more complications and longer hospital stay than patients with minimal RLI. Preoperative history of transarterial embolization (odds ratio [OR], 1.77; 95% CI, 1.02-3.03; P = .04), use of the Pringle maneuver (OR, 1.96; 95% CI, 1.08-3.58; P = .03), and longer operative time (OR, 1.003; 95% CI, 1.002-1.005; P < .001) were independent risk factors for severe RLI. Early recurrence rates within 6 (60.2% vs 9.6%) or 12 (79.6% vs 18.7%) months after hepatectomy were higher in patients with severe RLI than in patients without RLI (P < .001). Severe remnant liver ischemia was an independent risk factor for overall survival (OR, 6.98; 95% CI, 4.27-11.43; P < .001) and disease-free survival (OR, 5.15; 95% CI, 3.62-7.35; P < .001).
Preventive management and technical refinements in hepatectomy are important to decrease the risk of RLI and to improve survival of patients with hepatocellular carcinoma.
肝切除术后的残余肝脏可能血供不足,尤其是在非解剖性切除或血管损伤后。
评估残余肝脏缺血(RLI)是否会对肝细胞癌患者肝切除术后的长期生存和发病率产生不利影响。
设计、地点和参与者:本研究是对首尔国立大学盆唐医院的一项回顾性分析。对2004年1月1日至2013年12月31日期间因肝细胞癌接受肝切除术的328例患者的术后计算机断层扫描进行残余肝脏缺血分级。
残余肝脏缺血定义为静脉期对比增强减弱或消失。残余肝脏缺血分为轻度(无或边缘性)或重度(部分性、节段性或坏死性)。
在328例患者(男性252例,女性76例;年龄范围26 - 83岁[平均年龄58.2岁])中,98例(29.9%)发现有重度RLI的放射学征象,其中分别有63例、16例和19例为部分性、节段性或坏死性RLI。与轻度RLI患者相比,这些患者经历了更多并发症且住院时间更长。术前经动脉栓塞史(比值比[OR],1.77;95%可信区间[CI],1.02 - 3.03;P = 0.04)、使用普林格尔手法(OR,1.96;95% CI,1.08 - 3.58;P = 0.03)以及手术时间较长(OR,1.003;95% CI,1.002 - 1.005;P < 0.001)是重度RLI的独立危险因素。肝切除术后6个月(60.2%对9.6%)或12个月(79.6%对18.7%)内,重度RLI患者的早期复发率高于无RLI患者(P < 0.001)。重度残余肝脏缺血是总生存(OR,6.98;95% CI,4.27 - 11.43;P < 0.001)和无病生存(OR,5.15;95% CI,3.62 - 7.35;P < 0.001)的独立危险因素。
肝切除术中的预防性管理和技术改进对于降低RLI风险及提高肝细胞癌患者的生存率很重要。